Stock screener

AMLX

Conviction 87HealthcareScan · Thu, Sep 24, 2026

Amylyx Pharmaceuticals, Inc. (AMLX) closed at $30.16 (-1.45%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 45, RS Rating 98, -23.9% from its 52-week high, +164.1% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

AMLX$30.16-1.45%
ResistanceSupportVol 14Insider buyInsider sell
63 bars
10
Vol MA14 1.58M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Amylyx Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.amylyx.com ↗
Price30.16
Change-1.45%
Gap+0.60%
Rel volume1.36×
Avg volume1.68M
Avg $ vol55.57M
SMA 2033.20
SMA 5027.98
SMA 20018.04
Price vs 50+7.79%
Price vs 200+67.16%
MA stackbullish
50/200 cross—
Supertrenddown · 35.55
RSI (14)45
MACD hist-0.79
MACD cross—
Stoch %K / %D7 / 16
ADX (14)30
+DI / −DI22 / 25
RSI divergence—
MACD divergence—
ATR %5.92%
ADR %4.96%
52w high39.66
52w low11.38
From 52w high-23.95%
Above 52w low+165.03%
New 52w highNo
SqueezeOff
Bollinger width18.10%
%B-0.01
Donchian pos3.81%
Donchian high38.23
Donchian low29.84
AVWAP (52w high)34.73
vs AVWAP high-13.17%
AVWAP (52w low)21.60
vs AVWAP low+39.60%
OBV trendDown
Chaikin MF (20)-0.20
Today vs 20d1.36×
Avg vol (14d)1.58M
Avg vol (20d)1.68M
Avg $ vol (20d)55.57M
Market cap3.36B
RS Rating98 / 99
RS 3m (vs SPY)+68.44%
RS 6m (vs SPY)+101.26%
RS line new highNo
Trend template8/8
Technical rank77.1
1 week-11.14%
1 month-19.49%
3 months+72.94%
6 months+118.08%
1 year+123.74%
YTD+164.10%
P/E-23.22
P/B14.05
P/S—
P/FCF-27.21
EPS-1.53
Div yield—
ROE-60.52%
ROA-54.71%
Debt/Eq—
Current12.12
EV/EBITDA—
Gross margin—
Net margin—
Rev growth-100.00%
EPS growth52.03%
Price target45.86
Target upside52.06%
Analyst ratingBuy
Institutional100.44%
Ent. value3.31B
Revenue0
Net income-43.42M
Gross profit—
Free cash flow-123.48M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out111.19M
Employees136
ListedFri, Jan 7, 2022
Free float87.41M
Float %79.6%
Short interest12.74M
Days to cover2.4d
Short volume45.4%
Squeeze score50 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.39 vs −$0.36
Last surprise-8.3% miss
Setup gradeA
Conviction87 / 100
Pattern quality—
Tech rank77.1 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance38.31
Support20.29
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Recent news

Congress activity

Disclosed STOCK Act trades in AMLX

All disclosures →
No recent disclosed trades by Congress in AMLX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AMLX · open-market 10 sells

InsiderSideShares
Klee Justin B.
Co-Chief Executive Officer · Common Stock · 2026-09-10
Sell29.02K
Klee Justin B.
Co-Chief Executive Officer · Common Stock · 2026-09-10
Sell1.44K
Cohen Joshua B
Co-Chief Executive Officer · Common Stock · 2026-09-10
Sell29.55K
Cohen Joshua B
Co-Chief Executive Officer · Common Stock · 2026-09-10
Sell919
Mazzariello Gina
Chief Legal Officer · Common Stock · 2026-09-10
Sell9.53K
Mazzariello Gina
Chief Legal Officer · Common Stock · 2026-09-10
Sell11
FRATES JAMES M
Chief Financial Officer · Common Stock · 2026-09-10
Sell9.77K
FRATES JAMES M
Chief Financial Officer · Common Stock · 2026-09-10
Sell1.04K
Bedrosian Camille L
Chief Medical Officer · Common Stock · 2026-09-10
Sell7.95K
Bedrosian Camille L
Chief Medical Officer · Common Stock · 2026-09-10
Sell2.08K

SEC filings

EDGAR filings in AMLX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.